Chandran Ka

781 total citations
20 papers, 246 citations indexed

About

Chandran Ka is a scholar working on Hematology, Genetics and Nutrition and Dietetics. According to data from OpenAlex, Chandran Ka has authored 20 papers receiving a total of 246 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 12 papers in Genetics and 11 papers in Nutrition and Dietetics. Recurrent topics in Chandran Ka's work include Iron Metabolism and Disorders (13 papers), Hemoglobinopathies and Related Disorders (12 papers) and Trace Elements in Health (11 papers). Chandran Ka is often cited by papers focused on Iron Metabolism and Disorders (13 papers), Hemoglobinopathies and Related Disorders (12 papers) and Trace Elements in Health (11 papers). Chandran Ka collaborates with scholars based in France, Belgium and Guadeloupe. Chandran Ka's co-authors include Gérald Le Gac, Claude Férec, Isabelle Gourlaouen, Isabelle Callebaut, Pierre Lehn, Jean‐Paul Mornon, Yann Fichou, Silvia Majore, Jian‐Min Chen and Cédric Le Maréchal and has published in prestigious journals such as Nucleic Acids Research, The FASEB Journal and International Journal of Molecular Sciences.

In The Last Decade

Chandran Ka

19 papers receiving 242 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chandran Ka France 9 185 146 121 50 38 20 246
Paul Toran United States 5 242 1.3× 195 1.3× 150 1.2× 69 1.4× 32 0.8× 12 321
Isabelle Gourlaouen France 8 196 1.1× 164 1.1× 153 1.3× 37 0.7× 11 0.3× 17 231
Riffat Ahmed United States 5 185 1.0× 154 1.1× 113 0.9× 49 1.0× 21 0.6× 5 249
L-H. Gu United States 9 193 1.0× 251 1.7× 12 0.1× 49 1.0× 44 1.2× 29 313
Outi Kämäräinen United Kingdom 4 49 0.3× 44 0.3× 36 0.3× 62 1.2× 8 0.2× 6 133
Ina Hollerer Germany 8 44 0.2× 36 0.2× 31 0.3× 214 4.3× 10 0.3× 10 273
Jinqin Liu China 7 74 0.4× 58 0.4× 4 0.0× 60 1.2× 7 0.2× 24 142
Marta Polo Spain 7 87 0.5× 79 0.5× 7 0.1× 11 0.2× 22 0.6× 18 115
Mylène Béri‐Dexheimer France 6 54 0.3× 34 0.2× 3 0.0× 45 0.9× 22 0.6× 8 159
Peter Hawkins United States 8 82 0.4× 98 0.7× 4 0.0× 57 1.1× 103 2.7× 13 193

Countries citing papers authored by Chandran Ka

Since Specialization
Citations

This map shows the geographic impact of Chandran Ka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chandran Ka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chandran Ka more than expected).

Fields of papers citing papers by Chandran Ka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chandran Ka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chandran Ka. The network helps show where Chandran Ka may publish in the future.

Co-authorship network of co-authors of Chandran Ka

This figure shows the co-authorship network connecting the top 25 collaborators of Chandran Ka. A scholar is included among the top collaborators of Chandran Ka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chandran Ka. Chandran Ka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ged, Cécile, Kévin Uguen, Isabelle Gourlaouen, et al.. (2025). Identification of New Key Players for Ferrous Iron Export in the Asymmetric Inner Gate of Human Ferroportin 1. The FASEB Journal. 39(14). e70821–e70821.
2.
Uguen, Kévin, et al.. (2024). Insights into the role of glycerophospholipids on the iron export function of SLC40A1 and the molecular mechanisms of ferroportin disease. The FASEB Journal. 38(13). e23725–e23725. 3 indexed citations
3.
4.
Uguen, Kévin, Dimitri Tchernitchko, Isabelle Gourlaouen, et al.. (2024). The dual loss and gain of function of the FPN1 iron exporter results in the ferroportin disease phenotype. Human Genetics and Genomics Advances. 5(4). 100335–100335. 2 indexed citations
5.
Uguen, Kévin, Chandran Ka, Gwenaëlle Collod‐Béroud, et al.. (2023). The Spectra of Disease-Causing Mutations in the Ferroportin 1 (SLC40A1) Encoding Gene and Related Iron Overload Phenotypes (Hemochromatosis Type 4 and Ferroportin Disease). Human Mutation. 2023. 1–22. 4 indexed citations
6.
Ka, Chandran, Gaëlle Richard, Isabelle Callebaut, et al.. (2021). Missense RHD single nucleotide variants induce weakened D antigen expression by altering splicing and/or protein expression. Transfusion. 61(8). 2468–2476. 3 indexed citations
7.
Ka, Chandran, et al.. (2021). Insights into the Role of the Discontinuous TM7 Helix of Human Ferroportin through the Prism of the Asp325 Residue. International Journal of Molecular Sciences. 22(12). 6412–6412. 4 indexed citations
8.
Ka, Chandran, Isabelle Gourlaouen, Gaëlle Richard, et al.. (2020). Splicing analysis of SLC40A1 missense variations and contribution to hemochromatosis type 4 phenotypes. Blood Cells Molecules and Diseases. 87. 102527–102527. 5 indexed citations
9.
Dujardin, Gwendal, Adeline Busson, Pascal Trouvé, et al.. (2020). TIMP1 intron 3 retention is a marker of colon cancer progression controlled by hnRNPA1. Molecular Biology Reports. 47(4). 3031–3040. 5 indexed citations
10.
Rodríguez‐Palmero, Agustí, Agatha Schlüter, Edgard Verdura, et al.. (2020). A novel hypomorphic splice variant in EIF2B5 gene is associated with mild ovarioleukodystrophy. Annals of Clinical and Translational Neurology. 7(9). 1574–1579. 4 indexed citations
11.
Ka, Chandran, Isabelle Gourlaouen, Isabelle Callebaut, et al.. (2019). Functional analysis of novel RHD variants: splicing disruption is likely to be a common mechanism of variant D phenotype. Transfusion. 59(4). 1367–1375. 14 indexed citations
12.
Uguen, Kévin, Isabelle Gourlaouen, Claude Férec, et al.. (2019). Molecular model of the ferroportin intracellular gate and implications for the human iron transport cycle and hemochromatosis type 4A. The FASEB Journal. 33(12). 14625–14635. 14 indexed citations
13.
Ka, Chandran, Caroline Kannengiesser, Cécile Ged, et al.. (2018). The SLC40A1 R178Q mutation is a recurrent cause of hemochromatosis and is associated with a novel pathogenic mechanism. Haematologica. 103(11). 1796–1805. 20 indexed citations
14.
Berlivet, Soizik, et al.. (2015). Analysis of long-range interactions in primary human cells identifies cooperativeCFTRregulatory elements. Nucleic Acids Research. 44(6). 2564–2576. 19 indexed citations
15.
Gac, Gérald Le, Chandran Ka, Isabelle Gourlaouen, et al.. (2013). Structure-Function Analysis of the Human Ferroportin Iron Exporter (SLC40A1): Effect of Hemochromatosis Type 4 Disease Mutations and Identification of Critical Residues. Human Mutation. 34(10). 1371–1380. 47 indexed citations
16.
Fichou, Yann, Cédric Le Maréchal, Chandran Ka, et al.. (2012). Establishment of a medium‐throughput approach for the genotyping of RHD variants and report of nine novel rare alleles. Transfusion. 53(8). 1821–1828. 37 indexed citations
17.
Gac, Gérald Le, Silvia Majore, Chandran Ka, et al.. (2009). A novel missense mutation in SLC40A1 results in resistance to hepcidin and confirms the existence of two ferroportin‐associated iron overload diseases. British Journal of Haematology. 147(3). 379–385. 32 indexed citations
18.
19.
Scotet, Virginie, Gérald Le Gac, Chandran Ka, et al.. (2005). Impact of HFEgenetic testing on clinical presentation of hereditary hemochromatosis: new epidemiological data. BMC Medical Genetics. 6(1). 24–24. 15 indexed citations
20.
Ka, Chandran, Gérald Le Gac, François‐Yves Dupradeau, Jacques Rochette, & Claude Férec. (2005). The Q283P amino-acid change in HFE leads to structural and functional consequences similar to those described for the mutated 282Y HFE protein. Human Genetics. 117(5). 467–475. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Toran Breakdown of academic impact, for papers by Isabelle Gourlaouen Breakdown of academic impact, for papers by Riffat Ahmed Breakdown of academic impact, for papers by L-H. Gu Breakdown of academic impact, for papers by Outi Kämäräinen Breakdown of academic impact, for papers by Ina Hollerer Breakdown of academic impact, for papers by Jinqin Liu Breakdown of academic impact, for papers by Marta Polo Breakdown of academic impact, for papers by Mylène Béri‐Dexheimer Breakdown of academic impact, for papers by Peter Hawkins
Rankless by CCL
2026